Markets have been speculating on the possible delisting
Unreasonably high prices of drugs, introduced by companies such as Dr Reddy's Laboratories Ltd, Ranbaxy Laboratories Ltd, Cipla, Switzerland-headquartered F Hoffmann-La Roche Ltd and Novartis AG,
Stay informed on our latest news!
